Abstract
Several analogues of the amino acid sequence of peptide 9-21 of glycoprotein D of herpes simplex virus type 1 (HSV-1) were synthesized and investigated for reactivity with different group VII monoclonal antibodies, Mabs LP14, ID3, 170, HD4, A16, EII-24 and Ev-10, in a competition enzyme-linked immunosorbent assay (ELISA). Replacement of Arg at position 16 by His resulted in a loss of binding with the group VII Mabs. Substitution of Pro at residue 14 by Leu gave a reduced binding for a number of Mabs and loss of binding for Mab A16. Substitution of Lys at position 10 by Glu gave reduced binding for three out of the seven Mabs. In addition substitutions of Met at position 11 by norleucine and oxidized Met were studied. The boundaries of the epitope cluster were mapped by studying synthetic variants of peptide 9-21 which were shorter either at the C-terminus or at the N-terminus, or both. Peptide 10-18 and peptide 9-17 were the shortest peptides, which were still reactive with the group VII Mabs. Mab HD4 requires the N-terminus of peptide 9-21 for effective binding, while for binding of other Mabs contribution of the residues in the C-terminal part of this peptide is more important.
References
Aug 1, 1992·Journal of Virology·A O Fuller, W C Lee
Mar 1, 1991·Vaccine·E M MishkinS J Mento
Jan 1, 1991·Archives of Virology·H GhiasiS L Wechsler
Jun 1, 1990·Journal of Virology·D C JohnsonT Gregory
Sep 1, 1990·Virology·G Campadelli-FiumeB Roizman
Aug 1, 1990·The Journal of General Virology·H J GeerligsS Welling-Wester
Dec 1, 1990·Journal of Virology·G Campadelli-FiumeB Roizman
Jun 1, 1986·The Journal of General Virology·A C MinsonE A Buckmaster
Aug 1, 1986·European Journal of Biochemistry·M P WilliamsonB K Handa
Oct 1, 1986·Journal of Virology·G H CohenR J Eisenberg
Nov 1, 1987·Journal of Virology·S L HighlanderJ C Glorioso
Nov 1, 1987·Journal of Virology·D L BoschS Welling-Wester
May 1, 1989·Journal of Virology·V J IsolaG H Cohen
Nov 30, 1989·Journal of Immunological Methods·J R Van der PloegS Welling-Wester
Feb 1, 1985·Journal of Virology·R J EisenbergG H Cohen
Feb 1, 1988·Journal of Virology·W J WeijerK Slopsema
Aug 1, 1985·Journal of Virology·A O Fuller, P G Spear
Sep 1, 1985·Journal of Medical Virology·R D Dix, J Mills
Sep 1, 1986·Vaccine·M J Hall, K Katrak
Feb 1, 1987·The Journal of Experimental Medicine·E WatariE Heber-Katz
May 1, 1987·The Journal of Infectious Diseases·L R StanberryM G Myers
May 1, 1987·The Journal of Infectious Diseases·B MeignierB Roizman
Oct 1, 1988·Virology·G Campadelli-FiumeB Roizman
Jan 1, 1982·Infection and Immunity·L PereiraJ D Woodie
Feb 1, 1982·Journal of Virology·R J EisenbergG H Cohen
Jan 1, 1984·Journal of Virology·G H CohenR J Eisenberg
Oct 22, 1982·Science·R J WatsonL W Enquist
Feb 1, 1984·Infection and Immunity·D LongR J Eisenberg
Mar 1, 1980·Developmental Biology·C E WinterF J Lara
Sep 1, 1993·The Journal of General Virology·D X LiuC Lelliott
Citations
Nov 16, 1995·Journal of Immunological Methods·H S de KosterJ W Drijfhout
Oct 15, 2003·Biophysical Chemistry·Gitta SchlosserFerenc Hudecz
Aug 17, 2002·Protein Expression and Purification·Adriaan van KooijSytske Welling-Wester
Aug 15, 1996·European Journal of Biochemistry·E LasonderG W Welling
Jan 7, 2005·Journal of Peptide Science : an Official Publication of the European Peptide Society·Gábor MezöFerenc Hudecz
Feb 24, 2006·Biopolymers·Dimitrios KrikorianVassilios Tsikaris
Aug 5, 2011·Journal of Virology·Stephen J DolleryAnthony V Nicola
Mar 11, 2009·Bioconjugate Chemistry·Annamária JakabGábor Mezo